Skip to main content
SpringerLink
Log in

Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The levels of cyclic adenosine 3′:5′-monophosphate (cAMP) and cyclic guanosine 3′:5′-monophosphate (cGMP) were studied in dimethylbenz(a)anthracene (DMBA)-induced mammary tumors of Sprague-Dawley rats and in human breast cancer. In the rat carcinomas, these levels were significantly lower than in non-malignant tissues when calculated on the basis of DNA content, but higher (cAMP) or equal (cGMP) when calculated on the basis of weight. In human breast cancer the cyclic nucleotide levels were higher than in non-malignant tissues according to both methods of calculation. No correlation was found in human carcinomas between the cyclic nucleotide levels and mitotic index, nuclear grade, tumor size, or lymph node involvement. The rat tumors were subclassified according to state of differentiation, mitotic index, and state of development. Not all the sub-groups had cAMP levels different from normal values. Differences in cAMP levels between the sub-groups could not be correlated with tumor growth rates and/or mitotic index. Thus, cyclic nucleotides may not be useful in prognosis of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Heidrick ML, Ryan WL: Adenosine 3′:5′-cyclic monophosphate and contact inhibition. Cancer Res 31:1313–1315, 1971

    PubMed  Google Scholar 

  2. Otten J, Johnson G, Pastan I: Cyclic AMP levels in fibroblasts: Relationship to growth rate and contact inhibition of growth. Biochem Biophys Res Commun 44:192–198, 1971

    PubMed  Google Scholar 

  3. Sheppard JR: Differences in cyclic adenosine 3′5′-monophosphate levels in normal and transformed cells. Nature (New Biol) 236:14–16, 1972

    Google Scholar 

  4. Rudland PS, Seeley M, Seifert W: Cyclic GMP and cyclic AMP levels in normal and transformed fibroblasts. Nature 251:417–419, 1974

    PubMed  Google Scholar 

  5. Moens W, Vokaer A, Kram R: Cyclic AMP and cyclic GMP concentrations in serum- and density- restricted fibroblast cultures. Proc Natl Acad Sci USA 72:1063–1067, 1975

    PubMed  Google Scholar 

  6. Ryan WL, Heidrick ML: Role of cyclic nucleotides in cancer. Adv Cyclic Nucl Res 4:81–116, 1974

    Google Scholar 

  7. Somers KD: Increased cyclic AMP content directly correlated with morphological transformation of cells infected with a temperature sensitive mutant of mouse sarcoma virus. In Vitro 16: 851–858, 1980

    PubMed  Google Scholar 

  8. Green H: Cyclic AMP in relation to proliferation of the epidermal cell: a new view. Cell 15:801–811, 1978

    PubMed  Google Scholar 

  9. Marcelo CL: Differential effects of cAMP and cGMP on in vitro epidermal cell growth. Exptl Cell Res 120:201–210, 1979

    PubMed  Google Scholar 

  10. DeRubertis FR, Chayoth R, Field JB: The content and metabolism of cyclic adenosine 3′5′-monophosphate and cyclic guanosine 3′5′-monophosphate in adenocarcinoma of the human colon. J Clin Invest 57:641–649, 1976

    PubMed  Google Scholar 

  11. Stevens RH, Loven DP, Osborne JW, Prall JL: Cyclic nucleotide concentrations in 1,2-dimethylhydrazine and X-ray induced rat small intestinal cancer. Cancer Lett 4:325–332, 1978

    PubMed  Google Scholar 

  12. Stevens RH, Graves JM, Meek ES, Osborne JW, Chang HI, Loven DP: Cyclic nucleotide concentrations in 7,12-dimethylbenz(a)anthracene-induced pancreatic cancer in rats. J Natl Cancer Inst 61:1281–1284, 1978

    PubMed  Google Scholar 

  13. Boyd H, McAfee DA, Rubin JJ: A study of cyclic nucleotide metabolism and the histology of rat liver during 3′-methyl-4-dimethyl aminoazobenzene carcinogenesis. II. Cyclic AMP metabolism. Tissue and Cell 10:477–494, 1978

    PubMed  Google Scholar 

  14. Minton JP, Wisenbaugh T, Matthews RH: Elevated cyclic AMP levels in human breast cancer tissue. J Natl Cancer Inst 53:283–284, 1974

    PubMed  Google Scholar 

  15. Minton JP, Matthews RH, Wisenbaugh TW: Elevated adenosine 3′,5′-cyclic monophosphate levels in human and animal tumorsin vivo. J Natl Cancer Inst 57:39–41, 1976

    PubMed  Google Scholar 

  16. Rillema JA, Mulder JA, Anderson LD: Cyclic nucleotides and their associated enzymes in 9,10-dimethyl-1,2-benzanthracene induced mammary tumors of rats. Cancer Res 38:741–744, 1978

    PubMed  Google Scholar 

  17. Chatterjee SK, Kim U: Adenosine- 3′,5′-cyclic monophosphate levels and adenosine-3′,5′-monophosphate phosphodiesterase activity in metastasizing and nonmetastasizing rat mammary carcinomas. J Natl Cancer Inst 54:181–186, 1975

    PubMed  Google Scholar 

  18. Sidney JC, Black MM, Jorbjørn M, Harvey S, Freedman C: Further observations on prognostic factors in cancer of the female breast. Cancer 24:653–667, 1969

    PubMed  Google Scholar 

  19. Giles KW, Myers A: An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 206:93, 1965

    PubMed  Google Scholar 

  20. Murad F, Manganiello V, Vaughan M: A simple sensitive protein binding assay for guanosine 3′:5′-monophosphate. Proc Natl Acad Sci USA 68:736–739, 1971

    PubMed  Google Scholar 

  21. Schultz G, Hardman JH, Schultz K, Davis JW, Sutherland EW: A new enzymatic assay for guanosine 3′:5′-cyclic monophosphate and its application to the ductus deferens of the rat. Proc Natl Acad Sci USA 70:1721–1725, 1973

    PubMed  Google Scholar 

  22. Matusik RJ, Hilf R: Relationship of adenosine 3′,5′-cyclic monophosphate and guanosine 3′,5′-cyclic monophosphate to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats. J Natl Cancer Inst 56:659–661, 1976

    PubMed  Google Scholar 

  23. Gilman AG: A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 67:305–312, 1970

    PubMed  Google Scholar 

  24. Myamoto E, Kuo JF, Greengard P: Cyclic nucleotide-dependent protein kinases. III. Purification and properties of adenosine 3′,5′-monophophate dependent protein kinase from bovine brain. J Biol Chem 244:6395–6402, 1969

    PubMed  Google Scholar 

  25. Steiner AL, Parker CW, Kipnis DM: Radioimmunoassay for cyclic nucleotides. II. Adenosine 3′:5′-monophosphate and guanosine 3′-5′-monophosphate in mammalian tissues and body fluids. J Biol Chem 247:1114–1120, 1972

    PubMed  Google Scholar 

  26. Haslam SZ, Bern HA: Histogenesis of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Proc Natl Acad Sci USA 74:4020–4024, 1974

    Google Scholar 

  27. Guerinot F, Delarue JC, Contesso G, Bohuon C: Adenosine 3′,5′-cyclic monophosphate and guanosine 3′,5′-cyclic monophophate levels in human breast cancer tissue. Oncology 34:261–263, 1977

    PubMed  Google Scholar 

  28. Cohen LA, Chan PC: Intracellular cAMP levels in normal rat mammary gland and adenocarcinomain vivo vs.in vitro. Life Sci 16:107–115, 1975

    PubMed  Google Scholar 

  29. Sinha D, Dao TL: Site of origin of mammary tumors induced by 7,12-dimethylbenz(a)anthracene in the rat. J Natl Cancer Inst 54:1007–1009, 1975

    PubMed  Google Scholar 

  30. Lewison EF: Spontaneous regression of breast cancer. Natl Cancer Inst Monogr 44:23–26, 1976

    PubMed  Google Scholar 

  31. Cho-Chung YS, Bodwin JS, Clair T: Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression. Europ J Biochem 86:51–60, 1978

    PubMed  Google Scholar 

  32. Ip C, Dao TL: Regulation of cyclic adenosine 3′5′-monophosphate in relation to growth of dimethylbenz(a)anthracene induced mammary tumors in rats. Cancer Lett 8:227–233, 1980

    PubMed  Google Scholar 

  33. Singer AL, Sherwin RP, Dunn AS, Appleman MM: Cyclic nucleotide phosphodiesterases in neoplastic and non-neoplastic human mammary tissues. Cancer Res 36:60–66, 1976

    PubMed  Google Scholar 

  34. Cho-Chung YS, Clair T, Schwimmer M, Steinberg L, Rego J, Grantham F: Cyclic adenosine 3′5′-monophosphate receptor proteins in hormone dependent and independent rat mammary tumors. Cancer Res 41:1840–1846, 1981

    PubMed  Google Scholar 

  35. Eppenberger U, Biedermann K, Handschin JC, Fabbro D, Küng W, Huber PR, Roos W: cAMP dependent protein kinase type I and type II and cAMP binding in human mammary tumors. Adv Cyclic Nucl Res 12:123–128, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Endocrinological Institute, Rambam Medical Center, 31096, Haifa, Israel

    Ella Israeli, Batya Raz & David Barzilai

  2. Department of Pathology, Rambam Medical Center, Haifa, Israel

    Hedwiga Kerner

  3. Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

    Hedwiga Kerner & David Barzilai

Authors
  1. Ella Israeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Batya Raz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hedwiga Kerner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Barzilai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Israeli, E., Raz, B., Kerner, H. et al. Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development. Breast Cancer Res Tr 6, 241–248 (1985). https://doi.org/10.1007/BF01806775

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806775

Key words

Search

Navigation